Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Handbook of Experimental Pharmacology|October 11, 2017
Natural (and Unnatural) Small Molecules as Pharmacological Chaperones and Inhibitors in CancerIsabel Betancor-Fernández, David J Timson, Eduardo Salido, et al.
International Journal for Parasitology|July 24, 2012
A plasma membrane Ca(2+)-ATPase (PMCA) from the liver fluke, Fasciola hepaticaCatherine M Moore, Elizabeth M Hoey, Alan Trudgett, et al.
Journal of Personalized Medicine|February 10, 2021
Galactosemia: Towards Pharmacological ChaperonesSamantha Banford, Thomas J McCorvie, Angel L Pey, et al.
Biochimica Et Biophysica Acta|February 26, 2014
Biochemical characterisation of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from the liver fluke, Fasciola hepaticaVeronika L Zinsser, Elizabeth M Hoey, Alan Trudgett, et al.
Biochimie|August 27, 2013
Biochemical characterisation of triose phosphate isomerase from the liver fluke Fasciola hepaticaVeronika L Zinsser, Elizabeth M Hoey, Alan Trudgett, et al.
FEMS Yeast Research|February 16, 2011
Artemisinins act through at least two targets in a yeast modelCatherine M Moore, Elizabeth M Hoey, Alan Trudgett, et al.
Antioxidants (Basel, Switzerland)|August 23, 2020
The Catalytic Cycle of the Antioxidant and Cancer-Associated Human NQO1 Enzyme: Hydride Transfer, Conformational Dynamics and Functional CooperativityErnesto Anoz-Carbonell, David J Timson, Angel L Pey, et al.
The Journal of Physical Chemistry. B|November 21, 2017
Reaction Mechanism of Isopentenyl Phosphate Kinase: A QM/MM StudyJames McClory, David J Timson, Warispreet Singh, et al.
Yeast (Chichester, England)|July 7, 2011
Isolation of compensatory inhibitor domain mutants to novel activation domain variants using the split-ubiquitin screenRobert N Campbell, Frederick Westhorpe, Richard J Reece
Pageof 17